UBS AM’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-90,068
| Closed | -$302K | – | 2598 |
|
|
2023
Q2 | $302K | Hold |
90,068
| – | – | ﹤0.01% | 2474 |
|
|
2023
Q1 | $302K | Hold |
90,068
| – | – | ﹤0.01% | 2474 |
|
|
2022
Q4 | $433K | Buy |
90,068
+2,620
| +3% | +$12.6K | ﹤0.01% | 2232 |
|
|
2022
Q3 | $498K | Sell |
87,448
-14,138
| -14% | -$80.4K | ﹤0.01% | 2347 |
|
|
2022
Q2 | $721K | Buy |
101,586
+85,437
| +529% | +$607K | ﹤0.01% | 2133 |
|
|
2022
Q1 | $117K | Hold |
16,149
| – | – | ﹤0.01% | 2729 |
|
|
2021
Q4 | $144K | Buy |
16,149
+3,523
| +28% | +$31.5K | ﹤0.01% | 2795 |
|
|
2021
Q3 | $443K | Buy |
+12,626
| New | +$443K | ﹤0.01% | 2542 |
|